KIDNEY DIS-BASEL 润色咨询

Kidney Diseases

出版年份：暂无数据 年文章数：249 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1107111, encodeId=70f0110e1115f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107112, encodeId=2be4110e1125a, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566709, encodeId=cf6f566e099a, content=请问现在算SCI了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a52508294, createdName=x812252556_54970143, createdTime=Wed Feb 13 12:58:00 CST 2019, time=2019-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555756, encodeId=cf14555e56ae, content=什么时候能sci收录呢?期待着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Sun May 06 02:21:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555119, encodeId=4cbf555119fe, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d66d2330658, createdName=245663419_58890737, createdTime=Wed Apr 18 09:42:00 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    RUNNINGTITLE和TITLE的区别？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1107111, encodeId=70f0110e1115f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107112, encodeId=2be4110e1125a, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566709, encodeId=cf6f566e099a, content=请问现在算SCI了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a52508294, createdName=x812252556_54970143, createdTime=Wed Feb 13 12:58:00 CST 2019, time=2019-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555756, encodeId=cf14555e56ae, content=什么时候能sci收录呢?期待着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Sun May 06 02:21:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555119, encodeId=4cbf555119fe, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d66d2330658, createdName=245663419_58890737, createdTime=Wed Apr 18 09:42:00 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2021-12-28 rayms

    RUNINGTITLE的撰写方法？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1107111, encodeId=70f0110e1115f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107112, encodeId=2be4110e1125a, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566709, encodeId=cf6f566e099a, content=请问现在算SCI了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a52508294, createdName=x812252556_54970143, createdTime=Wed Feb 13 12:58:00 CST 2019, time=2019-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555756, encodeId=cf14555e56ae, content=什么时候能sci收录呢?期待着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Sun May 06 02:21:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555119, encodeId=4cbf555119fe, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d66d2330658, createdName=245663419_58890737, createdTime=Wed Apr 18 09:42:00 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2019-02-13 x812252556_54970143

    请问现在算SCI了吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1107111, encodeId=70f0110e1115f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107112, encodeId=2be4110e1125a, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566709, encodeId=cf6f566e099a, content=请问现在算SCI了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a52508294, createdName=x812252556_54970143, createdTime=Wed Feb 13 12:58:00 CST 2019, time=2019-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555756, encodeId=cf14555e56ae, content=什么时候能sci收录呢?期待着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Sun May 06 02:21:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555119, encodeId=4cbf555119fe, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d66d2330658, createdName=245663419_58890737, createdTime=Wed Apr 18 09:42:00 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2018-05-06 Franksix

    什么时候能sci收录呢?期待着

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1107111, encodeId=70f0110e1115f, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107112, encodeId=2be4110e1125a, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566709, encodeId=cf6f566e099a, content=请问现在算SCI了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a52508294, createdName=x812252556_54970143, createdTime=Wed Feb 13 12:58:00 CST 2019, time=2019-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555756, encodeId=cf14555e56ae, content=什么时候能sci收录呢?期待着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a751637456, createdName=Franksix, createdTime=Sun May 06 02:21:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555119, encodeId=4cbf555119fe, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d66d2330658, createdName=245663419_58890737, createdTime=Wed Apr 18 09:42:00 CST 2018, time=2018-04-18, status=1, ipAttribution=)]
    2018-04-18 245663419_58890737

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：国内肾脏领域的权威期刊，已经被Pubmed收录，静待被SCI纳入麾下。

    0

共8条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分